Insights

PTAB Invalidates Patent Claims on Gattex® Formulation, <i>PTAB Litigation</i>

PTAB Invalidates Patent Claims on Gattex® Formulation, PTAB Litigation

Visit the Jones Day PTAB Litigation Blog.

On October 21, 2016, the PTAB issued two final written decisions in cases IPR2015-00990 and IPR2015-01093, invalidating claims 1-27, 31-40, 44-52 and 61-75 of U.S. Patent 7,056,886. These decisions mark the first win for the Coalition for Affordable Drugs ("CFAD"), an organization started by the hedge fund manager Kyle Bass for the purpose of challenging drug patents.

Read the full article at ptabligitgationblog.com.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.